The Cancer Biologics Market Segment was valued at USD 102.2 billion in 2023 and is projected to experience robust growth, reaching USD 195.5 billion by 2032. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.5% over the forecast period from 2024 to 2032. This growth is driven by the increasing prevalence of cancer globally, advancements in biologic therapies, and the...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian